Travelers Companies (The) (TRV)

NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-10-15

$389.54+1.47%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Travelers Companies (The)’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.9%

+10% or more+5%0%−5%−10% or less

30.25 → 30.51 EPS · FY ending Dec 31, 2027 · 17 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 17 to 17; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Return at least $2.2 billion to shareholders in Q1 2026	Profit margins and capital return stay solid.	Intact	Capital returned falls below $2.2 billion in Q1 2026	Required source inputs unavailable Cannot calculate Cash returned to shareholders from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Capital returned to shareholders increased from about $600 million in 2025-Q1 to $1.577 billion in 2026-Q2, including share repurchases and dividend increases from $1.10 to $1.25 per share. The trajectory shows consistent and growing capital returns. Delivery assessment Oct 15, 2026
Core income grows to at least $1.7 billion in Q1 2026	Travelers grows core income strongly, reaching $1.7 billion in Q1 2026.	Intact	Core income falls below $1.7 billion in Q1 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Core income increased from $443 million in 2025-Q1 to $2.160 billion in 2026-Q2, driven by lower catastrophe losses and higher net favorable prior year reserve development. The trajectory is delivering strong core income growth and underwriting performance. Delivery assessment Oct 15, 2026
Expense ratio stays near 28.5% for full year 2026	The company aims to keep expense ratio near 28.5% in 2026.	Under Pressure	Expense ratio rises above 29% for FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$30.51

$30.00 → $30.51 · observed estimates

FY2027 revenue$45.30B

$45.23B → $45.30B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$30.00	$45,231,376,115	17 / 12
2026-07-25	$30.04	$44,671,354,840	27 / 14
2026-07-26	$30.04	$44,671,354,840	27 / 14
2026-07-27	$30.11	$44,699,000,000	27 / 12
2026-07-28	$30.17	$45,239,328,124	17 / 11
2026-07-29	$30.17	$45,239,328,124	17 / 11
2026-07-30	$30.16	$44,685,032,380	27 / 13
2026-07-31	$30.16	$44,685,032,380	27 / 13
2026-08-01	$30.23	$45,267,055,291	17 / 12
2026-08-02	$30.16	$44,685,032,380	27 / 13
2026-08-03	$30.16	$44,685,032,380	27 / 13
2026-08-04	$30.23	$45,267,055,291	17 / 12
2026-08-05	$30.22	$44,678,109,310	27 / 13
2026-08-06	$30.23	$45,267,055,291	17 / 12
2026-08-08	$30.23	$45,267,055,291	17 / 12
2026-08-09	$30.23	$45,267,055,291	17 / 12
2026-08-10	$30.23	$45,267,055,291	17 / 12
2026-08-12	$30.21	$44,697,285,080	27 / 12
2026-08-13	$30.23	$45,267,055,291	17 / 12
2026-08-14	$30.23	$45,267,055,291	17 / 12
2026-08-15	$30.23	$45,267,055,291	17 / 12
2026-08-16	$30.23	$45,267,055,291	17 / 11
2026-08-17	$30.23	$45,267,055,291	17 / 11
2026-08-18	$30.23	$45,267,055,291	17 / 11
2026-08-19	$30.23	$45,267,055,291	17 / 11
2026-08-20	$30.25	$45,240,694,199	17 / 11
2026-08-21	$30.25	$45,240,694,199	17 / 11
2026-08-22	$30.25	$45,240,694,199	17 / 11
2026-08-23	$30.25	$45,240,694,199	17 / 11
2026-08-24	$30.25	$45,240,694,199	17 / 11
2026-08-25	$30.25	$45,240,694,199	17 / 11
2026-08-26	$30.25	$45,240,694,199	17 / 11
2026-08-27	$30.25	$45,240,694,199	17 / 11
2026-08-28	$30.25	$45,240,694,199	17 / 11
2026-08-29	$30.25	$45,240,694,199	17 / 11
2026-08-30	$30.25	$45,240,694,199	17 / 11
2026-08-31	$30.25	$45,240,694,199	17 / 11
2026-09-01	$30.25	$45,240,694,199	17 / 11
2026-09-02	$30.25	$45,240,694,199	17 / 11
2026-09-03	$30.25	$45,240,694,199	17 / 11
2026-09-04	$30.25	$45,240,694,199	17 / 11
2026-09-05	$30.25	$45,240,694,199	17 / 11
2026-09-06	$30.25	$45,240,694,199	17 / 11
2026-09-07	$30.25	$45,240,694,199	17 / 11
2026-09-08	$30.25	$45,240,694,199	17 / 11
2026-09-09	$30.25	$45,240,694,199	17 / 11
2026-09-10	$30.25	$45,240,694,199	17 / 11
2026-09-11	$30.25	$45,240,694,199	17 / 11
2026-09-12	$30.25	$45,240,694,199	17 / 11
2026-09-13	$30.25	$45,240,694,199	17 / 11
2026-09-14	$30.25	$45,240,694,199	17 / 11
2026-09-15	$30.25	$45,240,694,199	17 / 11
2026-09-16	$30.25	$45,240,694,199	17 / 11
2026-09-17	$30.27	$45,240,694,199	17 / 11
2026-09-18	$30.27	$45,240,694,199	17 / 11
2026-09-19	$30.27	$45,240,694,199	17 / 11
2026-09-20	$30.27	$45,240,694,199	17 / 11
2026-09-21	$30.27	$45,240,694,199	17 / 11
2026-09-22	$30.29	$45,240,694,199	17 / 11
2026-09-23	$30.29	$45,240,694,199	17 / 11
2026-09-24	$30.31	$45,301,337,056	17 / 11
2026-09-25	$30.31	$45,301,337,056	17 / 12
2026-09-26	$30.31	$45,301,337,056	17 / 12
2026-09-27	$30.31	$45,301,337,056	17 / 12
2026-09-28	$30.31	$45,301,337,056	17 / 12
2026-09-29	$30.31	$45,301,337,056	17 / 12
2026-09-30	$30.31	$45,301,337,056	17 / 12
2026-10-01	$30.31	$45,301,337,056	17 / 12
2026-10-02	$30.36	$45,301,337,056	17 / 12
2026-10-03	$30.36	$45,301,364,163	17 / 11
2026-10-04	$30.36	$45,301,364,163	17 / 11
2026-10-05	$30.36	$45,301,364,163	17 / 11
2026-10-06	$30.36	$45,301,364,163	17 / 11
2026-10-07	$30.38	$45,301,364,163	17 / 11
2026-10-08	$30.39	$45,261,858,863	17 / 11
2026-10-09	$30.42	$45,261,858,864	17 / 12
2026-10-10	$30.47	$45,319,123,316	17 / 12
2026-10-11	$30.47	$45,319,123,316	17 / 12
2026-10-12	$30.47	$45,319,123,316	17 / 12
2026-10-13	$30.51	$45,301,133,593	17 / 11
2026-10-14	$30.51	$45,301,133,593	17 / 10
2026-10-15	$30.51	$45,301,133,593	17 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	8	18	3
2026-06-01	8	18	3
2026-07-01	8	18	7
2026-08-01	6	17	6
2026-09-01	6	17	6
2026-10-01	6	17	6

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 17 Hold · 6 Sell / Strong Sell

0 upgrades0 downgrades6 maintains

Recent actions · Sep 16–Oct 15 · 6 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Cantor FitzgeraldOct 7

$378.00New observation · no comparable prior

$0$207.90$415.80

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Return at least $2.2 billion to shareholders in Q1 2026Required source inputs unavailable
Core income grows to at least $1.7 billion in Q1 2026Direct metric needs a verified mapping
Expense ratio stays near 28.5% for full year 2026Published status: Under Pressure

Next proof point

Oct 16, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-10.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Travelers Companies (The) outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on consistent income growth and capital returns. The current thesis state is intact, supported by strong recent financial performance despite a medium confidence level.

What's priced into Travelers Companies (The)

The market appears to be pricing in a stretched valuation compared to peers, reflecting a durable premium. There is a slight expectations gap, indicating that investors may foresee modest growth in TRV's performance.

What the fundamentals likely do

Fundamentals are likely to remain stable, with management focused on maintaining expense ratios and sustaining core income growth. Recent results show strong underwriting performance, although there is a low probability of missing earnings expectations.

What Travelers Companies (The) hinges on

The thesis hinges on several factors, including management's ability to maintain guidance, the performance of sector peers, and potential changes in interest rates. Any cuts to guidance or shifts in the financial sector's performance could negatively impact TRV.